Coronavirus Update: Sinovac Gets $15m Towards CoronaVac Phase II, Remdesivir Early Access In UK

Progress For China's Vaccines

Multiple vaccine and drug developers across the world report progress and partnerships amid volatility in their shares.   

Coronavirus mask
• Source: Shutterstock

A Chinese firm racing to develop a coronavirus vaccine has received additional funding from investors. Beijing-based Sinovac Biotech Ltd. obtained $15m from Advantech Capital and Vivo Capital, raising $7.5m from each of the investors. The new funds will be used to accelerate Sinovac’s candidate, CoronaVac, into Phase II development.

In April, the company announced a Phase I study of the inactivated virus product and is planning to start the...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip